Concepedia

Peter Ward

PW

Statistics

Publications

19

Citations

580

H-Index

14

Active since

1980

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Medway School of Pharmacy

University of London

Molecular Discovery (United Kingdom)

The Queen's Medical Research Institute

Peter Ward is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, pharmacology, and biochemistry.

Publications per year

1980–2011

19

Publications

19

Do metastases arise from pre-existing subpopulations of cancer cells?

L. Weiss, Janet Holmes, Peter Ward · British Journal of Cancer · 1983 · 70 citations

, , +14

GSK256066, an Exceptionally High-Affinity and Selective Inhibitor of Phosphodiesterase 4 Suitable for Administration by Inhalation: In Vitro, Kinetic, and In Vivo Characterization

Cathy Tralau-Stewart, Richard A. Williamson, Anthony T. Nials et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 69 citations

, , +17

Peptide synthesis. Part 7. Solid-phase synthesis of conotoxin G1

Eric Atherton, R. C. Sheppard, Peter Ward · Journal of the Chemical Society Perkin Transactions 1 · 1985 · 62 citations

, , +11

Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration

Michael D. Woodrow, Stuart P. Ballantine, Michael D. Barker et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 56 citations

, , +13

Discovery and biological evaluation of adamantyl amide 11β-HSD1 inhibitors

Scott P. Webster, Peter Ward, Margaret Binnie et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 53 citations · Full text

, , +14

1–5 of 19